Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects
- 1 September 2005
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 289 (3), E504-E507
- https://doi.org/10.1152/ajpendo.00099.2005
Abstract
The rate of gastric emptying of glucose-containing liquids is a major determinant of postprandial glycemia. The latter is also dependent on stimulation of insulin secretion by glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Although overall emptying of glucose approximates 1–3 kcal/min, the “early phase” of gastric emptying is usually more rapid. We have evaluated the hypothesis that increased stimulation of incretin hormones and insulin by a more rapid initial rate of small intestinal glucose delivery would reduce the overall glycemic response to a standardized enteral glucose load. Twelve healthy subjects were studied on two separate days in which they received an intraduodenal (id) glucose infusion for 120 min. On one day, the infusion rate was variable, being more rapid (6 kcal/min) between t = 0 and 10 min and slower (0.55 kcal/min) between t = 10 and 120 min, whereas on the other day the rate was constant (1 kcal/min) from t = 0–120 min, i.e., on both days 120 kcal were given. Between t = 0 and 75 min, plasma insulin, GIP, and GLP-1 were higher with the variable infusion. Despite the increase in insulin and incretin hormones, blood glucose levels were also higher. Between t = 75 and 180 min, blood glucose and plasma insulin were lower with the variable infusion. There was no difference in the area under the curve 0–180 min for blood glucose. We conclude that stimulation of incretin hormone and insulin release by a more rapid initial rate of id glucose delivery does not lead to an overall reduction in glycemia in healthy subjects.Keywords
This publication has 27 references indexed in Scilit:
- Clinical Significance, Pathogenesis, and Management of Postprandial HyperglycemiaArchives of Internal Medicine, 2003
- Postprandial hypotension in response to duodenal glucose delivery in healthy older subjectsJournal Of Physiology-London, 2002
- Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic PatientsJournal of Clinical Endocrinology & Metabolism, 2001
- The effect of short-term dietary supplementation with glucose on gastric emptying of glucose and fructose and oral glucose tolerance in normal subjectsDiabetologia, 1996
- Gastric emptying and release of incretin hormones after glucose ingestion in humans.JCI Insight, 1996
- Treatment With an Oral Proteinase Inhibitor Slows Gastric Emptying and Acutely Reduces Glucose and Insulin Levels After a Liquid Meal in Type II Diabetic PatientsDiabetes Care, 1994
- Relationship between oral glucose tolerance and gastric emptying in normal healthy subjectsDiabetologia, 1993
- Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.JCI Insight, 1993
- Reduced incretin effect in Type 2 (non-insulin-dependent) diabetesDiabetologia, 1986
- The incretin concept todayDiabetologia, 1979